AdvancednervousPhysiology
The Basal Ganglia Circuit
Overview
The basal ganglia select and gate actions through opponent direct (go) and indirect (no-go) pathways from striatum through pallidum to thalamus and back to cortex. Dopamine from the substantia nigra pars compacta facilitates the direct pathway via D1 receptors and suppresses the indirect via D2 — and its loss in Parkinson's disease locks the circuit toward 'no-go', producing bradykinesia and rigidity.
Learning objectives
- Name the core nuclei and their connections.
- Explain direct-pathway disinhibition of the thalamus.
- Explain indirect-pathway suppression via GPe/STN.
- Describe dopamine's opposite effects on D1 vs D2 neurons.
- Relate pathway imbalance to Parkinson's and Huntington's disease.
Process steps
Widespread cortical areas project excitatory glutamatergic input to the striatum (caudate + putamen) — the input stage representing candidate movements and action plans.
Striatal D1-expressing neurons inhibit the GPi/SNr output nuclei. Since GPi/SNr tonically inhibit the thalamus, this inhibition-of-inhibition releases thalamocortical drive — a 'go' signal for the selected action.
Striatal D2 neurons inhibit the GPe, disinhibiting the subthalamic nucleus (STN); the STN excites GPi/SNr, strengthening thalamic inhibition — a 'no-go' signal suppressing competing actions.
Nigrostriatal dopamine excites D1 (direct/go) and inhibits D2 (indirect/no-go) striatal neurons — facilitating wanted movement and suppressing unwanted movement simultaneously.
The net GPi/SNr output sets thalamic activity, which projects back to frontal cortex — closing the loop that selects one action while suppressing its competitors.
Key variables
| Variable | Unit | Typical range | Role |
|---|---|---|---|
| Striatal output split | qualitative | D1 direct / D2 indirect | Two opponent populations from the same cortical input; balance sets movement. |
| Dopamine effect on D1 | direction | excitatory | Gs-coupled D1 receptors facilitate the go pathway. |
| Dopamine effect on D2 | direction | inhibitory | Gi-coupled D2 receptors suppress the no-go pathway. |
| Loop transit time | ms | tens | Fast enough for real-time action selection during movement. |
Feedback loops
Direct pathway disinhibition positive feedback
- Cortex excites D1 striatal neurons
- GPi/SNr inhibited
- Thalamus disinhibited
- Cortical motor drive for the selected action increases
Indirect pathway suppression negative feedback
- Cortex excites D2 striatal neurons
- GPe inhibited, STN disinhibited
- GPi/SNr excited
- Thalamic drive to competing actions suppressed
An action-selection machine
The basal ganglia do not generate movement commands — they permit them. Cortex proposes; the basal ganglia's tonic inhibitory output (GPi/SNr → thalamus) blocks everything by default, releasing only the selected action. Think of a bouncer, not a choreographer.
Both pathways work by modulating tonic inhibition: direct pathway inhibits the inhibitors (go); indirect pathway strengthens the inhibitors (no-go). Selection emerges from the balance.
The direct (go) pathway
Cortex → D1 striatum → GPi/SNr (inhibited) → thalamus (released) → cortex. Dopamine excites D1 neurons, so dopamine boosts the go signal — facilitating initiation of chosen movements.
The indirect (no-go) pathway
Cortex → D2 striatum → GPe (inhibited) → STN (released) → GPi/SNr (excited) → thalamus (suppressed). Dopamine inhibits D2 neurons, so dopamine normally damps this brake. The hyperdirect pathway (cortex → STN) adds a fast global stop signal.
When the balance breaks
Parkinson's (dopamine loss): direct weakens, indirect strengthens — thalamus over-inhibited, movements hard to start (bradykinesia, rigidity). Huntington's (early D2 neuron loss): indirect fails first — unwanted movements escape (chorea). Opposite lesions, opposite symptoms, same circuit logic.
Key points
- Striatum → direct (D1, go) and indirect (D2, no-go) pathways converge on GPi/SNr.
- GPi/SNr tonically inhibit thalamus; pathways modulate this inhibition.
- Dopamine excites D1 and inhibits D2 — promoting selected movement.
- Parkinson's: dopamine loss → overactive no-go → bradykinesia.
- Huntington's: early indirect loss → chorea.
Common misconceptions
✓ Truth: They gate and select among cortically proposed actions. Initiation drive comes from cortex; the basal ganglia decide which proposals pass — loss produces inability to release wanted movement, not paralysis of command.
✓ Truth: Dopamine tunes the go/no-go balance; both too little (Parkinson's) and dysregulated signaling produce movement disorders. It is a modulator of selection, not a gas pedal.
✓ Truth: They share input (striatum) and output (GPi/SNr→thalamus→cortex) stages, interacting continuously — opponent processes within one integrated circuit, not two isolated wires.
Practice questions
Q1. In the direct pathway, striatal D1 activation ultimately:
- inhibits the thalamus
- disinhibits the thalamus by inhibiting GPi/SNr
- excites the STN
- blocks dopamine release
D1 neurons inhibit the tonically active GPi/SNr output nuclei, releasing thalamocortical neurons from inhibition — the 'go' signal.
Q2. Dopamine's effect on the indirect pathway is to:
- excite D2 neurons
- inhibit D2 striatal neurons, reducing no-go output
- destroy the GPe
- block the STN
Via Gi-coupled D2 receptors, dopamine suppresses the indirect pathway — one half of its pro-movement tuning (the other half excites D1).
Q3. Early Huntington's disease preferentially damages striatal neurons of the:
- direct pathway, causing bradykinesia
- indirect pathway, causing chorea
- hyperdirect pathway only
- cortical input layer
Early loss of D2 (indirect) neurons weakens the no-go brake, letting unwanted movements escape as chorea — the mirror image of Parkinson's.
Click a question to reveal the answer and explanation.
Frequently asked questions
Why does dopamine loss cause slowness rather than weakness?
Strength is intact — the deficit is in releasing selected actions: overactive indirect output keeps the thalamic gate shut, so movements are hard to initiate and execute (bradykinesia), not weak.
What is the hyperdirect pathway?
A fast cortical projection straight to the STN that rapidly boosts GPi/SNr inhibition — a global 'stop' signal that pauses all actions while the direct/indirect competition resolves.
How does deep brain stimulation help Parkinson's?
High-frequency STN or GPi stimulation disrupts the pathological overactive indirect-pathway output, partially restoring thalamocortical drive — functionally loosening the excessive brake.